JP2017510400A5 - - Google Patents

Download PDF

Info

Publication number
JP2017510400A5
JP2017510400A5 JP2016575315A JP2016575315A JP2017510400A5 JP 2017510400 A5 JP2017510400 A5 JP 2017510400A5 JP 2016575315 A JP2016575315 A JP 2016575315A JP 2016575315 A JP2016575315 A JP 2016575315A JP 2017510400 A5 JP2017510400 A5 JP 2017510400A5
Authority
JP
Japan
Prior art keywords
item
composition
self
solution
assembling peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016575315A
Other languages
English (en)
Japanese (ja)
Other versions
JP6554121B2 (ja
JP2017510400A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/019740 external-priority patent/WO2015138475A1/en
Publication of JP2017510400A publication Critical patent/JP2017510400A/ja
Publication of JP2017510400A5 publication Critical patent/JP2017510400A5/ja
Application granted granted Critical
Publication of JP6554121B2 publication Critical patent/JP6554121B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016575315A 2014-03-10 2015-03-10 気管支閉鎖剤としての自己組織化ペプチド Expired - Fee Related JP6554121B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461950529P 2014-03-10 2014-03-10
US61/950,529 2014-03-10
US201461953146P 2014-03-14 2014-03-14
US61/953,146 2014-03-14
PCT/US2015/019740 WO2015138475A1 (en) 2014-03-10 2015-03-10 Self-assembling peptides as bronchial obstruction agents

Publications (3)

Publication Number Publication Date
JP2017510400A JP2017510400A (ja) 2017-04-13
JP2017510400A5 true JP2017510400A5 (enExample) 2018-05-31
JP6554121B2 JP6554121B2 (ja) 2019-07-31

Family

ID=52737414

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016575315A Expired - Fee Related JP6554121B2 (ja) 2014-03-10 2015-03-10 気管支閉鎖剤としての自己組織化ペプチド

Country Status (5)

Country Link
US (2) US20170173221A1 (enExample)
EP (1) EP3116523B1 (enExample)
JP (1) JP6554121B2 (enExample)
ES (1) ES2706492T3 (enExample)
WO (1) WO2015138475A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3238749B2 (en) 2008-10-06 2025-06-04 3-D Matrix, Ltd. Tissue plug
EP3466964A1 (en) 2012-07-06 2019-04-10 3-D Matrix Ltd. Fill-finish process for peptide solutions
EP3628337B1 (en) 2014-03-10 2025-05-28 3-D Matrix, Ltd. Sterilization and filtration of peptide compositions
CN117138022A (zh) * 2014-03-10 2023-12-01 三维矩阵有限责任公司 自组装肽组合物
WO2015138478A1 (en) 2014-03-10 2015-09-17 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary bulla
US10814038B2 (en) 2016-01-06 2020-10-27 3-D Matrix, Ltd. Combination compositions
EP3723726A1 (en) 2017-12-15 2020-10-21 3-D Matrix, Ltd. Surfactant peptide nanostructures and uses in drug delivery
EP3818071A2 (en) * 2018-07-03 2021-05-12 3-D Matrix, Ltd. Ionic self-assembling peptides
WO2021202577A1 (en) 2020-03-31 2021-10-07 3-D Matrix, Ltd. Sterilization of self-assembling peptides by irradiation
WO2022035783A2 (en) * 2020-08-10 2022-02-17 Gel4Med, Inc. Topical and parenteral use and administration of self-assembling amphiphilic peptide hydrogels
US20250281676A1 (en) * 2020-08-10 2025-09-11 Gel4Med, Inc. Delivery of cells and tissues with self-assembling peptide hydrogel materials
US20240398868A1 (en) * 2020-08-10 2024-12-05 Gel4Med, Inc. Self-assembling amphiphilic peptide hydrogels

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2421638A1 (en) * 2000-09-11 2002-03-21 Closure Medical Corporation Bronchial occlusion method and apparatus
WO2003096972A2 (en) * 2002-05-13 2003-11-27 Massachusetts Institute Of Technology Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
HUE037994T2 (hu) * 2006-04-25 2018-09-28 Massachusetts Inst Technology Készítmények és eljárások szennyezõ anyagok, testfolyadékok vagy más anyagok mozgásának befolyásolására és/vagy más fiziológiai állapotok befolyásolására
EP3238749B2 (en) * 2008-10-06 2025-06-04 3-D Matrix, Ltd. Tissue plug
EP2750687B1 (en) * 2011-09-02 2017-12-06 3-D Matrix, Ltd. Amphiphilic peptides for thoracic air leakage occlusion
WO2015138478A1 (en) * 2014-03-10 2015-09-17 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary bulla

Similar Documents

Publication Publication Date Title
JP2017513928A5 (enExample)
JP2017513927A5 (enExample)
US10952961B2 (en) Implants and constructs including hollow fibers
JP6554121B2 (ja) 気管支閉鎖剤としての自己組織化ペプチド
JP2019528320A5 (enExample)
JP2016515113A5 (enExample)
KR20110081204A (ko) 트레프로스티닐의 폐 심부 전달
JP2015129129A (ja) 肺高血圧症のための治療
RU2018136580A (ru) Цитратная соль (s)-4-((s)-3-фтор-3-(2-(5,6,7,8-тетрагидро-1,8-нафтиридин-2-ил)этил)пирролидин-1-ил)-3-(3-(2-метоксиэтокси)фенил)бутановой кислоты
JP2025515491A5 (enExample)
Mangoni et al. A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model
KR101835895B1 (ko) 목시플록사신을 귀에 도포하기 위한 방법 및 조성물
ES2774773T3 (es) Agente terapéutico para la osteoporosis
RU2020109705A (ru) Соединения и их фармацевтические композиции для применения в лечении фиброзных заболеваний
JP2019518569A5 (enExample)
Guevara et al. Porcupine quill migration in the thoracic cavity of a German shorthaired pointer
Ursella et al. The use of non-invasive ventilation in the treatment of acute cardiogenic pulmonary edema.
ES2661173T3 (es) Combinación de solución de aminoácidos y un derivado de gelatina para inhibir la absorción renal
O’Callaghan et al. Pulmonary hypertension and left heart disease: emerging concepts and treatment strategies
Calenda et al. Duration of pain after a combination of peribulbar anesthesia and local anesthetic in the ball after enucleation or evisceration: 115 cases
Vandenberg et al. 111In-labeled platelet scintigraphy and two-dimensional echocardiography for detection of left atrial appendage thrombi. Studies in a new canine model.
Pitsiou et al. Successful up-front combination therapy in a patient with idiopathic pulmonary hypertension and patent foramen ovale: an alternative to epoprostenol therapy?
US10052429B2 (en) Devices and methods for lung volume reduction
Latsios et al. Substitution of ethanol with specially designed microspheres in a TASH procedure
Bergmann et al. Clinical Cases in LAA Occlusion: Indication, Techniques, Devices, Implantation